Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey.

Auteurs : Paillaud E, Soubeyran P, Caillet P, Cudennec T, Brain E, Terret C, Etchepare F, Mourey L, Aparicio T, Pamoukdjian F, Audisio RA, Rostoft S, Hurria A, Bellera C, Mathoulin-Pélissier S, + collaborators (among others :, Bron D
Jaar : 2018
Journal : Eur J Cancer
Volume : 103
Pagina's : 61-68

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Auteurs : Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes Da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA, + collaborators (among others :, Bron D
Jaar : 2018
Journal : N Engl J Med
Volume : 379
Pagina's : 934-947

Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies.

Auteurs : Aftimos P, Rolfo C, Rottey S, Offner F, Bron D, Maerevoet M, Soria JC, Moshir M, Dreier T, Van Rompaey L, Michot JM, Silence K, Hultberg A, Gandini D, de Haard H, Ribrag V, Peeters M, Thibault A, Leupin N, Awada A
Jaar : 2017
Journal : Clin Cancer Res
Volume : 23(21)
Pagina's : 6411-6420

A phase III randomized trial comparing Inolimomab vs. usual care in steroid-resistant acute GVHD.

Auteurs : Socié G, Vigouroux S, Yakoub-Agha I, Bay JO, Fürst S, Bilger K, Suarez F, Michallet M, Bron D, Gard P, Medeghri Z, Lehert P, Lai C, Corn T, Vernant JP
Jaar : 2017
Journal : Blood
Volume : 129(5)
Pagina's : 643-9

Reply to M. Lambertini et al.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas RO, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2017
Journal : J Clin Oncol
Volume : 35(7)
Pagina's : 805-6

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2017
Journal : Br J Haematol
Volume : 179 (5)
Pagina's : 846-848

Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study.

Auteurs : Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, Dubruille S, Etienne AM, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Straetmans N, Van Den Neste E, Bron D, Razavi D
Jaar : 2017
Journal : Psychooncology
Volume : 26(12)
Pagina's : 2086-2093

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures.

Auteurs : Fayyad-Kazan M, Fayyad-Kazan H, Merimi M, Meuleman N, Bron D, Lagneaux L, Najar M
Jaar : 2017
Journal : Data Brief
Volume : 11
Pagina's : 442-445

Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming.

Auteurs : Fayyad-Kazan H, Fayyad-Kazan M, Badran B, Bron D, Lagneaux L, Najar M
Jaar : 2017
Journal : J Transl Med
Volume : 15
Pagina's : 10

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma.

Auteurs : Dreyling M, Morschhauser F, Bouabdallah K, Bron D, Cunningham D, Assouline SE, Verhoef G, Linton K, Thieblemont C, Vitolo U, Hiemeyer F, Giurescu M, Garcia-Vargas J, Gorbatchevsky I, Liu L, Koechert K, Peña C, Neves M, Childs BH, Zinzani PL
Jaar : 2017
Journal : Ann Oncol
Volume : 28(9)
Pagina's : 2169-2178

Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant.

Auteurs : Dosin G, Aoun F, El Rassy E, Assi T, Lewalle P, Blanc J, Van Velthoven R, Bron D
Jaar : 2017
Journal : Clin Lymphoma Myeloma Leuk
Volume : 17(7)
Pagina's : 438-442

Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells.

Auteurs : Raicevic G, Najar M, Busser H, Crompot E, Bron D, Toungouz M, Lagneaux L
Jaar : 2017
Journal : Sci Rep
Volume : 7(1)
Pagina's : 2896

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B-cells from apoptosis, enhance their migration and induce gene expression modifications.

Auteurs : Crompot E, Van Damme M, Pieters K, Vermeersch M, Perez-Morga D, Mineur P, Maerevoet M, Meuleman N, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2017
Journal : Haematologica
Volume : 102(9)
Pagina's : 1594-1604

Unmet needs in the scientific approach to older patients with lymphoma.

Auteurs : Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B
Jaar : 2017
Journal : Haematologica
Volume : 102
Pagina's : 972-975

Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review.

Auteurs : Najar M, Krayem M, Meuleman N, Bron D, Lagneaux L
Jaar : 2017
Journal : Immune Netw
Volume : 17
Pagina's : 89-102

Rational therapeutic choice for older patients with lymphoma.

Auteurs : Bron D, Soubeyran P
Jaar : 2017
Journal : Curr Opin Oncol
Volume : 29
Pagina's : 322-327

New therapeutic approaches in cutaneous T-cell lymphomas

Auteurs : Bron D, Springael C, Maerevoet M, De Vicq M, Kolivras A
Jaar : 2017
Journal : Belgian J Hematology
Volume : 8
Pagina's : 102-6

Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.

Auteurs : Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D, Bodaghi B, LeHoang P, Bergstrom C, Grossniklaus HE, Chan CC, Peer J, Caspers LE
Jaar : 2017
Journal : Ocul Immunol Inflamm
Volume : 25(5)
Pagina's : 639-648

Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study.

Auteurs : Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, Dubruille S, Etienne AM, Liénard A, Merckaert I, Reynaert C, Slachmuylder JL, Straetmans N, Neste EV, Bron D, Razavi D
Jaar : 2017
Journal : Psychooncology
Volume : 26(1)
Pagina's : 118-24

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2016
Journal : Clin Epigenetics
Volume : 8
Pagina's : 132